EP3446684A4 - Schmelztablette - Google Patents
Schmelztablette Download PDFInfo
- Publication number
- EP3446684A4 EP3446684A4 EP17813385.6A EP17813385A EP3446684A4 EP 3446684 A4 EP3446684 A4 EP 3446684A4 EP 17813385 A EP17813385 A EP 17813385A EP 3446684 A4 EP3446684 A4 EP 3446684A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- orally disintegrating
- disintegrating tablet
- tablet
- orally
- disintegrating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006191 orally-disintegrating tablet Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016120056 | 2016-06-16 | ||
PCT/JP2017/022119 WO2017217491A1 (ja) | 2016-06-16 | 2017-06-15 | 口腔内崩壊錠 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3446684A1 EP3446684A1 (de) | 2019-02-27 |
EP3446684A4 true EP3446684A4 (de) | 2019-06-19 |
EP3446684B1 EP3446684B1 (de) | 2021-11-17 |
Family
ID=60663425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17813385.6A Active EP3446684B1 (de) | 2016-06-16 | 2017-06-15 | Schmelztablette |
Country Status (6)
Country | Link |
---|---|
US (1) | US20190328674A1 (de) |
EP (1) | EP3446684B1 (de) |
JP (1) | JP6496084B2 (de) |
ES (1) | ES2900566T3 (de) |
PT (1) | PT3446684T (de) |
WO (1) | WO2017217491A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6504638B1 (ja) * | 2018-05-31 | 2019-04-24 | 武田テバファーマ株式会社 | 錠剤及びその製造方法 |
JP7134048B2 (ja) * | 2018-09-28 | 2022-09-09 | ホソカワミクロン株式会社 | 測定評価装置及びそれによる評価方法 |
WO2020246120A1 (ja) * | 2019-06-07 | 2020-12-10 | あゆみ製薬株式会社 | 口腔内崩壊錠及びその製造方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1203580A1 (de) * | 1999-06-18 | 2002-05-08 | Takeda Chemical Industries, Ltd. | Rasch zerfallende feste zubereitungen |
EP2810659A1 (de) * | 2012-02-03 | 2014-12-10 | Asahi Kasei Chemicals Corporation | Im mund zerfallende tablette mit granulat zur überdeckung des bitteren geschmacks |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2944700A (en) * | 1999-03-15 | 2000-10-04 | Kaken Pharmaceutical Co., Ltd. | Quickly disintegrating tablets and process for producing the same |
JP3415835B2 (ja) * | 2000-06-30 | 2003-06-09 | 山之内製薬株式会社 | 口腔内速崩壊錠およびその製造法 |
GB0204771D0 (en) * | 2002-02-28 | 2002-04-17 | Phoqus Ltd | Fast disintegrating tablets |
WO2009041651A1 (ja) * | 2007-09-27 | 2009-04-02 | Mitsubishi Tanabe Pharma Corporation | 速崩壊性固形製剤 |
EP2719377B1 (de) * | 2011-06-10 | 2018-04-18 | Nipro Corporation | Verfahren zur herstellung von im mund zersetzbaren tabletten |
WO2013180248A1 (ja) * | 2012-05-31 | 2013-12-05 | 旭化成ケミカルズ株式会社 | セルロース粉末 |
JP2015218322A (ja) * | 2014-05-21 | 2015-12-07 | 旭化成ケミカルズ株式会社 | 微小澱粉粒子及びその製造方法 |
-
2017
- 2017-06-15 JP JP2018523995A patent/JP6496084B2/ja active Active
- 2017-06-15 ES ES17813385T patent/ES2900566T3/es active Active
- 2017-06-15 US US16/309,375 patent/US20190328674A1/en not_active Abandoned
- 2017-06-15 PT PT178133856T patent/PT3446684T/pt unknown
- 2017-06-15 EP EP17813385.6A patent/EP3446684B1/de active Active
- 2017-06-15 WO PCT/JP2017/022119 patent/WO2017217491A1/ja unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1203580A1 (de) * | 1999-06-18 | 2002-05-08 | Takeda Chemical Industries, Ltd. | Rasch zerfallende feste zubereitungen |
EP2810659A1 (de) * | 2012-02-03 | 2014-12-10 | Asahi Kasei Chemicals Corporation | Im mund zerfallende tablette mit granulat zur überdeckung des bitteren geschmacks |
Non-Patent Citations (2)
Title |
---|
ANONYMOUS: "Pharmaceutical dosage forms: tablets", vol. 1, 2008, INFORMA HEALTHCARE, New York, USA, XP002789571 * |
See also references of WO2017217491A1 * |
Also Published As
Publication number | Publication date |
---|---|
PT3446684T (pt) | 2021-12-16 |
ES2900566T3 (es) | 2022-03-17 |
US20190328674A1 (en) | 2019-10-31 |
EP3446684A1 (de) | 2019-02-27 |
JP6496084B2 (ja) | 2019-04-03 |
EP3446684B1 (de) | 2021-11-17 |
JPWO2017217491A1 (ja) | 2019-04-04 |
WO2017217491A1 (ja) | 2017-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL262312A (en) | Disintegrating tablets for oral administration | |
EP3406237A4 (de) | Tablettenkassette | |
EP3494064A4 (de) | Pillenförderer | |
EP3549585A4 (de) | Im mund zerfallende tablette mit einem diaminderivat | |
EP3254665A4 (de) | Tablettenkartusche | |
EP3449912A4 (de) | Schmelztablette | |
EP3328360A4 (de) | Im mund zerfallende tofacitinib-tabletten | |
HK1232170A1 (zh) | 速效口溶膜劑 | |
EP3329921A4 (de) | Tablette | |
EP3106152A4 (de) | Im mund zerfallende, mit film beschichtete tablette | |
EP3340847A4 (de) | Toilette | |
EP3556345A4 (de) | Im mund zerfallende tablette mit carbamatverbindung | |
EP3384765A4 (de) | Toilette | |
EP3113770A4 (de) | Oral zerfallende tablette aus nabilonhaltigen mannitolbasierten granulaten | |
PL3257511T3 (pl) | Tabletka rozpadająca się w jamie ustnej i sposób jej wytwarzania | |
EP3471708A4 (de) | Stabile, oral zersetzende pharmazeutische zusammensetzungen | |
EP3446684A4 (de) | Schmelztablette | |
EP3612165A4 (de) | Schnell zerfallende tablette | |
EP3023109A4 (de) | Schmelztablette | |
EP3504657A4 (de) | Kapazitive autocodierung | |
PL3174533T3 (pl) | Tabletka ulegająca rozpadowi w jamie ustnej | |
EP3445494A4 (de) | Brecher | |
EP3288556A4 (de) | Oral zerfallende zusammensetzungen | |
EP3320908A4 (de) | Bakterienhaltige, oral schnell zerfallende tablette | |
EP3733166A4 (de) | Zyklische oral zerfallende tablette |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20181122 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/00 20060101ALI20190507BHEP Ipc: A61K 9/00 20060101ALI20190507BHEP Ipc: A61K 9/20 20060101AFI20190507BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20190517 |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20200306 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602017049534 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A61K0009200000 Ipc: A61K0031135000 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/135 20060101AFI20210504BHEP Ipc: A61K 31/197 20060101ALI20210504BHEP Ipc: A61K 31/4184 20060101ALI20210504BHEP Ipc: A61K 9/00 20060101ALI20210504BHEP Ipc: A61K 9/20 20060101ALI20210504BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20210611 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602017049534 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1447498 Country of ref document: AT Kind code of ref document: T Effective date: 20211215 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Ref document number: 3446684 Country of ref document: PT Date of ref document: 20211216 Kind code of ref document: T Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20211209 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2900566 Country of ref document: ES Kind code of ref document: T3 Effective date: 20220317 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20211117 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1447498 Country of ref document: AT Kind code of ref document: T Effective date: 20211117 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220217 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220317 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220217 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220218 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602017049534 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20220818 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20220630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220615 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220615 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220630 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230427 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 20230601 Year of fee payment: 7 Ref country code: FR Payment date: 20230628 Year of fee payment: 7 Ref country code: DE Payment date: 20230630 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230623 Year of fee payment: 7 Ref country code: ES Payment date: 20230830 Year of fee payment: 7 Ref country code: CH Payment date: 20230702 Year of fee payment: 7 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20170615 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211117 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240621 Year of fee payment: 8 |